JPRN-UMIN000009493Recruiting未知
Efficacy and safety of DPP-4 inhibitors in patients with chronic kidney disease - DPP-4 inhibitors in CKD
ihon University School of Medicine0 sites30 target enrollmentStarted: December 7, 2012Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 85years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Exclusion criteria are the presence of infectious disease, thyroid disease, malignant tumors and treatment with steroids.
Investigators
Similar Trials
Completed
Not Applicable
Efficacy and safety of DPP-4 inhibitors in patients with chronic kidney diseaseJPRN-UMIN000018464ihon University School of Medicine100
Completed
Not Applicable
Efficacy and safety of DPP-4 inhibitor added to insulin for treatment of type 2 diabetesType 2 diabetesJPRN-UMIN000004678Keio University , School of Mecidicine, Department of Internal Medicine50
Completed
Not Applicable
The efficacy and the safety of the DPP4 inhibitor in patients with type 2 diabetes complicated with renal dysfunctiodiabetes mellitusJPRN-UMIN000030172Osaka Saiseikai Noe Hospital400
Completed
Not Applicable
A Study of Safety and Efficacy of DPP-4 inhibitor in the Treatment of type 2 diabetes in KanagawaType 2 diabetesJPRN-UMIN000014382Diabetes Committee, Kanagawa Physicians Association860
Completed
Not Applicable
Clinical study examining effect of DPP-4 inhibitors on postprandial hyperlipidemiaType 2 diabetes mellitusJPRN-UMIN000010177Shimane University Faculty of Medicine30